And why inspection readiness is now a commercial differentiator.
RBQM is often discussed as a regulatory requirement. But for CROs, it has become something more. It’s now a factor in how Sponsors select partners, evaluate performance, and decide where to expand or reduce scope.
Understanding what Sponsors are actually looking for requires looking beyond the framework itself.
The Regulatory Baseline
Under ICH E6(R3), expectations are clear. Organizations must be able to demonstrate:
- That the right risks were identified
- That oversight was proportionate to those risks
- That decisions were documented and justified
This is no longer about proving that activities occurred. It’s about proving that decisions were thoughtful, appropriate, and supported by evidence.
What Sponsors Add to That Equation
Sponsors are asking those same questions, but with a commercial lens.
They want to know:
- Can this CRO explain how it approaches RBQM?
- Can it apply that approach consistently across studies?
- Can it operate effectively across different delivery models and environments?
And increasingly:
- Can it demonstrate this in practice, not just in principle?
Because Sponsors are not buying a framework. They’re buying execution.
Why Inspection Readiness Matters Earlier
Historically, inspection readiness was something CROs prepared for at the end of a study.
Today, that expectation has shifted.
Sponsors want to see:
- How decisions are made during the study
- How risks are monitored and escalated
- How actions are tracked and verified
In other words, inspection readiness is no longer an endpoint. It’s a byproduct of how oversight is executed day to day.
From Compliance to Differentiation
This shift changes the role of RBQM. It’s no longer just about meeting regulatory expectations. It becomes a way to demonstrate consistency, transparency, and control.
CROs that can clearly articulate and demonstrate their RBQM model:
- Build trust more quickly
- Reduce friction in oversight discussions
- Position themselves as partners, not vendors
If they can’t, they risk being seen as easily replaceable.
The Commercial Impact
When Sponsors evaluate CROs, they’re not just assessing capability. They’re assessing confidence that:
- Risks will be identified early
- Decisions will be appropriate
- Oversight will be defensible
RBQM maturity directly influences that confidence. And that, in turn, influences:
- Win rates
- Renewal decisions
- Expansion opportunities
The Takeaway
RBQM is no longer just about compliance. It’s a commercial differentiator that defines how CROs compete. CROs that can demonstrate clear, consistent, and defensible oversight will stand out.
Not because they do more. But because they can explain what they do, and why.
→ Assess your RBQM operating model and see how it compares in the CRO RBQM Blueprint.
